IL-37 attenuated the development of IL-1β, IL-6, and TNF-α in sputum cells (LPS-stimulated) in asthma patients and caused suppression of IL-17 production more notably in patients with asthma than in healthy controls [15]. Here, IL6 is linked to asthma.